MORGAN STANLEY - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$14,859,949
+4.0%
1,130,894
-0.3%
0.00%
+100.0%
Q2 2023$14,294,724
+13.7%
1,134,502
+17.7%
0.00%0.0%
Q1 2023$12,575,581
-38.1%
963,646
-16.3%
0.00%
-50.0%
Q4 2022$20,311,967
-11.6%
1,151,472
-23.7%
0.00%
-33.3%
Q3 2022$22,982,000
-12.2%
1,508,949
-14.5%
0.00%0.0%
Q2 2022$26,184,000
+40.9%
1,765,614
+114.0%
0.00%0.0%
Q1 2022$18,583,000
+45.7%
825,192
+19.4%
0.00%
+50.0%
Q4 2021$12,750,000
+7.8%
691,023
-21.9%
0.00%0.0%
Q3 2021$11,824,000
-6.0%
884,383
+30.1%
0.00%0.0%
Q2 2021$12,583,000
-33.5%
679,742
-46.0%
0.00%
-33.3%
Q1 2021$18,909,000
+108.1%
1,259,348
+100.1%
0.00%
+200.0%
Q4 2020$9,088,000
+34.8%
629,316
-24.0%
0.00%0.0%
Q3 2020$6,743,000
+78.8%
828,367
+48.7%
0.00%0.0%
Q2 2020$3,772,000
+276.8%
557,238
+291.9%
0.00%
Q1 2020$1,001,000
-71.3%
142,179
-59.9%
0.00%
-100.0%
Q4 2019$3,483,000
+188.6%
354,832
+222.8%
0.00%
Q3 2019$1,207,000
+95.9%
109,932
+107.6%
0.00%
Q2 2019$616,000
-40.9%
52,948
-51.6%
0.00%
Q1 2019$1,043,000
-68.5%
109,313
-68.2%
0.00%
-100.0%
Q4 2018$3,310,000
-54.0%
343,350
-32.0%
0.00%
-50.0%
Q3 2018$7,189,000
-75.2%
504,604
-79.1%
0.00%
-75.0%
Q2 2018$28,972,000
+1.2%
2,414,341
+4.2%
0.01%0.0%
Q1 2018$28,628,000
-27.6%
2,318,101
-14.7%
0.01%
-27.3%
Q4 2017$39,562,000
+17.8%
2,719,015
+15.2%
0.01%
+10.0%
Q3 2017$33,582,000
+63.9%
2,359,985
+47.0%
0.01%
+66.7%
Q2 2017$20,489,000
-52.4%
1,605,749
-52.7%
0.01%
-14.3%
Q1 2017$43,072,000
-21.3%
3,396,866
-36.6%
0.01%
-22.2%
Q4 2016$54,698,000
+840.3%
5,357,134
+1113.0%
0.01%
+350.0%
Q3 2016$5,817,000
-69.7%
441,634
-70.8%
0.00%
-71.4%
Q2 2016$19,204,000
+62.4%
1,512,093
+68.9%
0.01%
+40.0%
Q1 2016$11,826,000
+48.0%
895,233
+72.3%
0.01%
+66.7%
Q4 2015$7,993,000
+17.5%
519,716
-5.2%
0.00%0.0%
Q3 2015$6,800,000
-59.0%
548,395
-54.7%
0.00%
-50.0%
Q2 2015$16,572,000
+115.6%
1,211,475
+88.5%
0.01%
+100.0%
Q1 2015$7,685,000
-17.9%
642,534
-12.3%
0.00%0.0%
Q4 2014$9,360,000
-38.8%
732,893
-35.7%
0.00%
-50.0%
Q3 2014$15,284,000
+2.7%
1,139,315
+22.9%
0.01%0.0%
Q2 2014$14,879,000
+1.8%
927,059
+14.4%
0.01%0.0%
Q1 2014$14,611,000
+24.6%
810,364
+6.9%
0.01%
+20.0%
Q4 2013$11,725,000
+47.2%
758,404
+41.6%
0.01%
+25.0%
Q3 2013$7,963,000
-59.4%
535,465
-64.7%
0.00%
-60.0%
Q2 2013$19,606,0001,515,1080.01%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q1 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 875,000$13,138,0002.70%
KESTREL INVESTMENT MANAGEMENT CORP 417,400$6,267,0002.63%
SHAPIRO CAPITAL MANAGEMENT LLC 16,933,530$127,255,604,0002.31%
Adirondack Research & Management Inc. 123,148$1,849,0002.19%
Smith, Graham & Co., Investment Advisors, LP 966,216$14,508,0001.18%
Lombard Odier Asset Management (Switzerland) SA 839,521$12,605,0000.84%
HENNESSY ADVISORS INC 946,800$14,216,0000.83%
Waterfront Wealth Inc. 95,403$1,464,0000.74%
Arjuna Capital 84,697$1,272,0000.62%
SummerHaven Investment Management, LLC 62,844$944,0000.58%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders